GL1X · GenesisL1 explorer

MolNFT v1 · #101762 · protein

The crystal structure of a mutant nampt (S165F) in complex with gne- 618

4O15 · Nicotinamide phosphoribosyltransferase: “The crystal structure of a mutant nampt (S165F) in complex with gne- 618”. X-ray diffraction, 2 ligands (2P1, PO4), 6 pockets (best druggability 0.86). MolNFT v1 #101762 on GenesisL1: 3D…

PDB
4O15
Type
protein
Length
931 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nicotinamide phosphoribosyltransferase
EC
2.4.2.12
UniProt
P43490
Ligands
2P1, PO4
Pockets
6 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46542% helix, 19% strandP43490
BNicotinamide phosphoribosyltransferase (EC 2.4.2.12)protein46641% helix, 19% strandP43490

Ligands and binding sites

  • 2P1 · N-(4-{[3-(trifluoromethyl)phenyl]sulfonyl}benzyl)-2H-pyrazolo[3,4-b]pyridine-5-carboxamide · ligand · 2 copies · chains A, B
  • PO4 · Phosphate ion · ion · 4 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16500.860.9195PO4, EDO, 2P1
22860.790.90492P1, PO4
37290.730.7962empty
4850.390.7816empty
5860.370.7615empty

Interfaces

1 interface between chains.

  • A–B · 4293 Ų buried · 77 hydrogen bonds · protein-protein

Compared structures

  • 4O15 · The crystal structure of a mutant NAMPT (S165F) in complex with GNE-618 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.